Amgen's $13.4bn Otezla Buy Helps Bristol/Celgene Merger Close By Year-End

 
• By Mandy Jackson
GoldKeyInPuzzle_1200x675
Selling Otezla to appease the FTC is key to closing the Bristol-Celgene merger on time. • Source: Shutterstock

More from Deals

More from Business